Xifeng Fei

768 total citations
38 papers, 606 citations indexed

About

Xifeng Fei is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xifeng Fei has authored 38 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Xifeng Fei's work include Cancer Cells and Metastasis (10 papers), Cancer Research and Treatments (7 papers) and MicroRNA in disease regulation (5 papers). Xifeng Fei is often cited by papers focused on Cancer Cells and Metastasis (10 papers), Cancer Research and Treatments (7 papers) and MicroRNA in disease regulation (5 papers). Xifeng Fei collaborates with scholars based in China, United States and Taiwan. Xifeng Fei's co-authors include Qiang Huang, Zhimin Wang, Zhong‐Qin Liang, Lei Shi, Zheng‐Hong Qin, Dongyi Jiang, Hanchun Chen, Jun Dong, Lingyun Li and Yuntian Shen and has published in prestigious journals such as Scientific Reports, Brain Research and Journal of neurosurgery.

In The Last Decade

Xifeng Fei

37 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xifeng Fei China 14 301 231 120 103 78 38 606
Fenghua Zhou China 16 448 1.5× 231 1.0× 95 0.8× 69 0.7× 124 1.6× 19 645
Meiqing Lou China 16 352 1.2× 142 0.6× 114 0.9× 94 0.9× 54 0.7× 40 705
Yajuan Xiao China 14 435 1.4× 136 0.6× 99 0.8× 115 1.1× 183 2.3× 27 690
Kenichiro Matsuda Japan 9 435 1.4× 160 0.7× 192 1.6× 246 2.4× 54 0.7× 35 694
Shengping Yu China 16 444 1.5× 256 1.1× 202 1.7× 200 1.9× 60 0.8× 45 883
Zhitao Jing China 17 519 1.7× 344 1.5× 109 0.9× 87 0.8× 52 0.7× 40 821
Ming-Teh Chen Taiwan 14 468 1.6× 296 1.3× 138 1.1× 128 1.2× 30 0.4× 21 699
Daochun Sun United States 11 523 1.7× 318 1.4× 178 1.5× 298 2.9× 63 0.8× 21 895
Elena Bianchetti United States 14 511 1.7× 191 0.8× 96 0.8× 185 1.8× 36 0.5× 21 709
Yuho Hayashi United States 9 469 1.6× 135 0.6× 174 1.4× 106 1.0× 69 0.9× 10 734

Countries citing papers authored by Xifeng Fei

Since Specialization
Citations

This map shows the geographic impact of Xifeng Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xifeng Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xifeng Fei more than expected).

Fields of papers citing papers by Xifeng Fei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xifeng Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xifeng Fei. The network helps show where Xifeng Fei may publish in the future.

Co-authorship network of co-authors of Xifeng Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Xifeng Fei. A scholar is included among the top collaborators of Xifeng Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xifeng Fei. Xifeng Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ma, Meng, Xifeng Fei, Dongyi Jiang, et al.. (2024). Research Progress on the Mechanism of Histone Deacetylases in Ferroptosis of Glioma. Oncology Reviews. 18. 1432131–1432131. 2 indexed citations
2.
Shi, Lei, Zhimin Wang, Xifeng Fei, et al.. (2023). Inhibition of TGF-β1-induced epithelial-mesenchymal transition in gliomas by DMC-HA. Aging. 15(24). 15183–15195. 2 indexed citations
3.
Fei, Xifeng, Xiaoyan Ji, Hui Tian, et al.. (2022). Quantitative proteomic dataset of whole protein in three melanoma samples of 92.1, 92.1-A and 92.1-B. Data in Brief. 45. 108592–108592. 1 indexed citations
5.
6.
Fei, Xifeng, Delin Wang, Jiawei Ma, et al.. (2018). Establishment of malignantly transformed dendritic cell line SU3-ihDCTC induced by Glioma stem cells and study on its sensitivity to resveratrol. BMC Immunology. 19(1). 7–7. 12 indexed citations
7.
Xiong, Yajie, Wenjun Ji, Fei Yao, et al.. (2016). Cathepsin L is involved in X-ray-induced invasion and migration of human glioma U251 cells. Cellular Signalling. 29. 181–191. 22 indexed citations
8.
Shen, Yuntian, Quanbin Zhang, Jinshi Zhang, et al.. (2015). Advantages of a dual-color fluorescence-tracing glioma orthotopic implantation model: Detecting tumor location, angiogenesis, cellular fusion and the tumor microenvironment. Experimental and Therapeutic Medicine. 10(6). 2047–2054. 5 indexed citations
9.
Wang, Wenjuan, Linmei Long, Long Wang, et al.. (2015). Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro. Cancer Letters. 371(2). 274–284. 37 indexed citations
10.
Chen, Yanming, Zhongyong Wang, Xingliang Dai, et al.. (2015). Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling. Cancer Letters. 365(2). 174–181. 23 indexed citations
11.
Shi, Lei, Xifeng Fei, Zhimin Wang, & Yongping You. (2015). PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway. In Vitro Cellular & Developmental Biology - Animal. 51(10). 1047–1055. 40 indexed citations
12.
Shi, Lei, Xifeng Fei, & Zhimin Wang. (2015). Demethoxycurcumin was prior to temozolomide on inhibiting proliferation and induced apoptosis of glioblastoma stem cells. Tumor Biology. 36(9). 7107–7119. 22 indexed citations
13.
Shi, Lei, Xifeng Fei, Guan Sun, et al.. (2014). Hypothermia Stimulates Glioma Stem Spheres to Spontaneously Dedifferentiate Adjacent Non-stem Glioma Cells. Cellular and Molecular Neurobiology. 35(2). 217–230. 10 indexed citations
14.
Wang, Aidong, Xingliang Dai, Xifeng Fei, et al.. (2014). Experimental research of host macrophage canceration induced by glioma stem progenitor cells. Molecular Medicine Reports. 11(4). 2435–2442. 22 indexed citations
15.
Wan, Yi, Xifeng Fei, Zhimin Wang, et al.. (2012). Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3. Chinese Journal of Cancer. 31(4). 207–214. 46 indexed citations
16.
Fei, Xifeng, et al.. (2011). Cathepsin L is involved in 6-hydroxydopamine induced apoptosis of SH-SY5Y neuroblastoma cells. Brain Research. 1387. 29–38. 24 indexed citations
17.
Dong, Jun, Yaodong Zhao, Qiang Huang, et al.. (2010). Glioma Stem/Progenitor Cells Contribute to Neovascularization via Transdifferentiation. Stem Cell Reviews and Reports. 7(1). 141–152. 71 indexed citations
18.
Li, Lingyun, Xiaoxia Wang, Xifeng Fei, et al.. (2010). Parkinson's disease involves autophagy and abnormal distribution of cathepsin L. Neuroscience Letters. 489(1). 62–67. 57 indexed citations
19.
Fei, Xifeng, Zheng‐Hong Qin, Lingyun Li, et al.. (2009). Olomoucine inhibits cathepsin L nuclear translocation, activates autophagy and attenuates toxicity of 6-hydroxydopamine. Brain Research. 1264. 85–97. 24 indexed citations
20.
Fei, Xifeng, Zheng‐Hong Qin, & Zhong‐Qin Liang. (2007). Contribution of CDP/Cux, a Transcription Factor, to Cell Cycle Progression. Acta Biochimica et Biophysica Sinica. 39(12). 923–930. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026